Literature DB >> 12154526

Pregnancy planning: a determinant of folic acid supplements use for the primary prevention of neural tube defects.

Pascale Morin1, Philippe De Wals, Denise St-Cyr-Tribble, Théophile Niyonsenga, Hélène Payette.   

Abstract

OBJECTIVE: Daily consumption of supplements containing 400 micrograms of folic acid in the periconception period may reduce the risk of neural tube defects (NTDs) by as much as 70%. However, despite explicit recommendations, folic acid consumption among women likely to become pregnant remains low. The objectives of this study were: to evaluate women's knowledge and beliefs with regard to folic acid; to estimate the frequency of vitamin supplement consumption; and to identify its determinants during the periconception period.
METHODS: In 1999-2000, a questionnaire was completed by 1,240 pregnant women in 10 Quebec hospitals.
RESULTS: Seventy percent of the respondents were aware of the preventive role of folic acid but only 25% had taken the recommended dose of supplements during the periconception period. Supplement consumption is associated with the pregnancy planning intensity score (OR: 1.06; 95% CI: 1.02-1.11), knowledge score (OR: 1.11; 95% CI: 1.07-1.16) and belief in the usefulness of supplements (OR: 1.56; 95% CI: 1.02-2.39).
CONCLUSION: These results indicate that further efforts are needed to inform the population and promote the optimal use of folic acid supplements.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154526

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  11 in total

1.  Determinants of the intention of preconception care use: lessons from a multi-ethnic urban population in the Netherlands.

Authors:  S Temel; E Birnie; H M Sonneveld; A J J Voorham; G J Bonsel; E A P Steegers; S Denktaş
Journal:  Int J Public Health       Date:  2012-08-08       Impact factor: 3.380

2.  Awareness and intake of folic acid for the prevention of neural tube defects among Lebanese women of childbearing age.

Authors:  Claudine Nasr Hage; Maya Jalloul; Mohamad Sabbah; Salim M Adib
Journal:  Matern Child Health J       Date:  2012-01

3.  Applying a knowledge-to-action framework for primary prevention of spina bifida in tropical Africa.

Authors:  Kasereka M Claude; Kwibuka L Juvenal; Michael Hawkes
Journal:  Matern Child Nutr       Date:  2010-11-09       Impact factor: 3.092

4.  [Multivitamin supplement for primary prevention of birth defects: application of a preventive clinical practice].

Authors:  Pascale Morin; Karine Demers; Christine Giguère; Denise St-Cyr Tribble; Julie Lane
Journal:  Can Fam Physician       Date:  2007-12       Impact factor: 3.275

5.  Awareness and use of folic acid among reproductive age and pregnant women.

Authors:  Gülengül N Köken; Aysel Uysal Derbent; Onur Erol; Nimet Saygın; Hülya Ayık; Mehmet Karaca
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-06-01

6.  Knowledge and use of folic acid for birth defect prevention among women of childbearing age in Shanghai, China: a prospective cross-sectional study.

Authors:  Huan Lian; Duan Ma; Shu-Feng Zhou; Xiaotian Li
Journal:  Med Sci Monit       Date:  2011-12

7.  Preconception healthcare: what women know and believe.

Authors:  Keith A Frey; Julia A Files
Journal:  Matern Child Health J       Date:  2006-06-08

8.  Knowledge and intake of folic acid to prevent neural tube defects among pregnant women in urban China: a cross-sectional study.

Authors:  Mingming Cui; Xiao-Lin Lu; Yan-Yu Lyu; Fang Wang; Xiao-Lu Xie; Xi-Yue Cheng; Ting Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-21       Impact factor: 3.007

9.  How well do blood folate concentrations predict dietary folate intakes in a sample of Canadian lactating women exposed to high levels of folate? An observational study.

Authors:  Lisa A Houghton; Kelly L Sherwood; Deborah L O'Connor
Journal:  BMC Pregnancy Childbirth       Date:  2007-10-25       Impact factor: 3.007

10.  Use of high doses of folic acid supplements in pregnant women in Spain: an INMA cohort study.

Authors:  Eva María Navarrete-Muñoz; Desirée Valera-Gran; Manoli García de la Hera; Daniel Gimenez-Monzo; Eva Morales; Jordi Julvez; Isolina Riaño; Adonina Tardón; Jesus Ibarluzea; Loreto Santa-Marina; Mario Murcia; Marisa Rebagliato; Jesus Vioque
Journal:  BMJ Open       Date:  2015-11-24       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.